IOncology Archives - Page 34 of 161

EBMT President-Elect Professor Ibrahim Yakoub-Agha: Allogeneic Hematopoietic Stem Cell Transplantation for Myeloproliferative Neoplasms

By Peng Longmei 2025.09.19

Editor’s Note: The 13th Lu Daopei Hematology Forum, jointly organized by the Beijing Health Promotion Association and the Guangzhou Hongmian Cancer and Rare Disease Foundation and hosted by the Beijing…

2025 COMB丨Professor Jiayu Wang: Balancing Individualized Treatment and Liver Function Preservation in Breast Cancer Liver Metastases

By Mourabit Halima 2025.09.19

Editor’s Note: Breast cancer liver metastases represent a major clinical challenge, requiring treatment strategies that balance anti-tumor efficacy with protection of liver function. At the 8th Conference on Oncology Precision…

Professor Ceshi Chen’s Speech at COMB 2025

By Mourabit Halima 2025.09.17

Professor Jiong Wu’s Speech at COMB 2025

By Lisa Cui 2025.09.17

Professor Peng Yuan’s Speech at COMB 2025

By Peter W. PENG 2025.09.17

Professor Tao Sun’s Speech at COMB 2025

By Mourabit Halima 2025.09.17

2025 COMB丨Professor Peng Yuan: Multi-Gene Testing Drives Personalized Treatment and Illuminates a New Era in Precision Breast Cancer Care

By Mourabit Halima 2025.09.14

Editor’s Note: The 8th Conference on Oncology Precision Medicine and the 11th Conference on Individualized Therapy for Breast Cancer were recently held in Beijing, jointly organized by the Beijing Breast…

Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer

By Mourabit Halima 2025.09.14

Editor’s Note: Endocrine resistance is one of the major challenges in the treatment of HR+/HER2- breast cancer. At the 8th Conference on Oncology Precision Medicine and the 11th Conference on…

Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal

By Peter W. PENG 2025.09.14

Editor’s Note: With China’s rapidly aging population, cancer prevention and treatment face new challenges and opportunities. As the birthplace of modern oncology in China, Tianjin Medical University Cancer Institute and…

Professor Xiaowei Qi: Preferred Neoadjuvant Strategies in HER2-Positive Breast Cancer and Breakthrough Directions in TNBC Immunotherapy

By Mourabit Halima 2025.09.14

Editor’s Note: The 2025 Summer Breast Cancer Forum · Northern Salon was held in Qingdao, Shandong, from August 8–10. Upholding the spirit of “learning and innovation” and the tradition of…